Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Goldberg

Showing results (1291-1300 of 1,605) with videos related to

Pageof 161
Sort By:
Microbiology (Reading, England)|June 11, 2002
Lysophosphatidic acid inhibition of the accumulation of Pseudomonas aeruginosa PAO1 alginate, pyoverdin, elastase and LasADavid C Laux, Joy M Corson, Michael Givskov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 27, 2018
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung CancerScott N Gettinger, Anna Wurtz, Sarah B Goldberg, et al.
Diabetes Care|January 28, 2009
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research GroupRonald B Goldberg, Marinella Temprosa, Steven Haffner, et al.
The Lancet. Oncology|February 10, 2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b studyScott Antonia, Sarah B Goldberg, Ani Balmanoukian, et al.
Diabetes Care|June 28, 2007
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemiaMark A Deeg, John B Buse, Ronald B Goldberg, et al.
Artificial Organs|February 2, 2022
High flow from Impella 5.5 with partial veno-arterial extracorporeal membrane oxygenation support: Case seriesSuguru Ohira, Stephen Pan, Avi Levine, et al.
Plos One|June 4, 2021
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patientsTue W Kragstrup, Helene Søgaard Singh, Ida Grundberg, et al.
Science Immunology|July 21, 2023
NLRP11 is a pattern recognition receptor for bacterial lipopolysaccharide in the cytosol of human macrophagesMaricarmen Rojas-Lopez, María Luisa Gil-Marqués, Vritti Kharbanda, et al.
The Plant Cell|January 10, 2001
Mutations in the FIE and MEA genes that encode interacting polycomb proteins cause parent-of-origin effects on seed development by distinct mechanismsR Yadegari, T Kinoshita, O Lotan, et al.
Clinical Therapeutics|December 26, 2007
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparisonDavid C Robbins, Paul J Beisswenger, Antonio Ceriello, et al.
Pageof 161

Showing results (1291-1300 of 1,605) with videos related to

Sort By:
Pageof 161
Microbiology (Reading, England)|June 11, 2002
Lysophosphatidic acid inhibition of the accumulation of Pseudomonas aeruginosa PAO1 alginate, pyoverdin, elastase and LasADavid C Laux, Joy M Corson, Michael Givskov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 27, 2018
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung CancerScott N Gettinger, Anna Wurtz, Sarah B Goldberg, et al.
Diabetes Care|January 28, 2009
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research GroupRonald B Goldberg, Marinella Temprosa, Steven Haffner, et al.
The Lancet. Oncology|February 10, 2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b studyScott Antonia, Sarah B Goldberg, Ani Balmanoukian, et al.
Diabetes Care|June 28, 2007
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemiaMark A Deeg, John B Buse, Ronald B Goldberg, et al.
Artificial Organs|February 2, 2022
High flow from Impella 5.5 with partial veno-arterial extracorporeal membrane oxygenation support: Case seriesSuguru Ohira, Stephen Pan, Avi Levine, et al.
Plos One|June 4, 2021
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patientsTue W Kragstrup, Helene Søgaard Singh, Ida Grundberg, et al.
Science Immunology|July 21, 2023
NLRP11 is a pattern recognition receptor for bacterial lipopolysaccharide in the cytosol of human macrophagesMaricarmen Rojas-Lopez, María Luisa Gil-Marqués, Vritti Kharbanda, et al.
The Plant Cell|January 10, 2001
Mutations in the FIE and MEA genes that encode interacting polycomb proteins cause parent-of-origin effects on seed development by distinct mechanismsR Yadegari, T Kinoshita, O Lotan, et al.
Clinical Therapeutics|December 26, 2007
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparisonDavid C Robbins, Paul J Beisswenger, Antonio Ceriello, et al.
Pageof 161